Panacea Life Sciences Holdings, Inc. Equity Securities, FV-NI, Unrealized Gain (Loss)
Panacea Life Sciences Holdings, Inc. (PLSH) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of $2.63 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2022-11-14
- 2022-09-30: Equity Securities, FV-NI, Unrealized Gain (Loss) 9 month $2.63M.
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 9 month |
|---|---|
| 2022-09-30 | $2.63M 10-Q · filed 2022-11-14 |